Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arkadiusz Z Dudek, M.D., Ph.D.
Big Ten Cancer Research Consortium
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Northwestern University, Robert H. Lurie Cancer Center
Chicago, Illinois, United States
- University of Illinois Cancer Center
Chicago, Illinois, United States
- University of Iowa, Holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Michigan State University, Breslin Cancer Center
Lansing, Michigan, United States
- University of Minnesota: Masonic Cancer Center
Minneapolis, Minnesota, United States
- University of Nebraska, Fred and Pamela Buffet Cancer Center
Omaha, Nebraska, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Penn State Hershey Cancer Institute
Hershey, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2015
- Primary completion
- 5 Dec 2019
- Completion
- 5 Dec 2019
- Last update posted
- 14 Sept 2022
- Registered enrollment
- 61
- Registry id
- NCT02348008
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.